Inventor
PALCHAUDHURI RAHUL
US20 patents
⚠️ This page may combine multiple inventors who share the name “PALCHAUDHURI RAHUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MAGENTA THERAPEUTICS INC
5 patentsUS10899843B2Jan 26, 2021
Compositions and methods for the depletion of CD117+ cells
MAGENTA THERAPEUTICS INC8 citations82
US10882915B2Jan 5, 2021
Compositions and methods for the depletion of CD117+ cells
MAGENTA THERAPEUTICS INC9 citations81
US11572411B2Feb 7, 2023
Anti-CD117 antibodies and conjugates
MAGENTA THERAPEUTICS INC2 citations68
US10576161B2Mar 3, 2020
Compositions and methods for the depletion of CD137+ cells
MAGENTA THERAPEUTICS INC1 citations58
US10434185B2Oct 8, 2019
Compositions and methods for the depletion of CD137+ cells
MAGENTA THERAPEUTICS INC1 citations58
UNIV ILLINOIS
5 patentsUS9611266B2Apr 4, 2017
Compounds and anti-tumor NQO1 substrates
UNIV ILLINOIS3 citations71
US9682060B2Jun 20, 2017
Small molecules that induce intrinsic pathway apoptosis
UNIV ILLINOIS0 citations52
US10285986B2May 14, 2019
Compounds and anti-tumor NQO1 substrates
UNIV ILLINOIS0 citations50
US9925180B2Mar 27, 2018
Compounds and anti-tumor NQO1 substrates
UNIV ILLINOIS0 citations50
US7709465B2May 4, 2010
Phosphorous containing compounds including triphenylmethylphosphonate esters for the treatment of melanoma and other cancers
UNIV ILLINOIS0 citations39
HARVARD COLLEGE
4 patentsUS10570207B2Feb 25, 2020
Compositions and methods for non-myeloablative conditioning
HARVARD COLLEGE5 citations82
US10280225B2May 7, 2019
Compositions and methods for non-myeloablative conditioning
HARVARD COLLEGE10 citations82
US12152080B2Nov 26, 2024
Compositions and methods for non-myeloablative conditioning
HARVARD COLLEGE0 citations61
US10906980B2Feb 2, 2021
Compositions and methods for non-myeloablative conditioning
HARVARD COLLEGE0 citations61